These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9498618)

  • 1. The effects of treatment with chemical agents or infection with feline viruses on protein-binding properties of the feline immunodeficiency virus long terminal repeat.
    Ikeda Y; Kawaguchi Y; Inoshima Y; Kohmoto M; Shimojima M; Inada G; Sato E; Kai C; Miyazawa T; Mikami T
    Virus Res; 1997 Oct; 51(2):203-12. PubMed ID: 9498618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory properties of the integrated long terminal repeat of the feline immunodeficiency virus.
    Ikeda Y; Kawaguchi Y; Tomonaga K; Inoshima Y; Kohmoto M; Miyazawa T; Mikami T
    Virus Res; 1996 Apr; 41(2):201-7. PubMed ID: 8738180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
    Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
    Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
    Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.
    Thompson FJ; Elder J; Neil JC
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():545-54. PubMed ID: 8126451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-binding properties of the putative AP-1 and ATF sequences in the feline immunodeficiency virus long terminal repeat.
    Ikeda Y; Inoshima Y; Kawaguchi Y; Maeda K; Kohmoto M; Kai C; Miyazawa T; Mikami T
    J Gen Virol; 1998 Jan; 79 ( Pt 1)():95-9. PubMed ID: 9460929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feline herpesvirus type 1 ICP4 down-regulates feline immunodeficiency virus long terminal repeat (LTR)-directed gene expression via the C/EBP site in the LTR.
    Kawaguchi Y; Maeda K; Pecoraro MR; Inoshima Y; Jang HK; Kohmoto M; Iwatsuki K; Ikeda Y; Shimojima M; Tohya Y
    J Vet Med Sci; 1995 Dec; 57(6):1129-31. PubMed ID: 8720064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of feline immunodeficiency virus long terminal repeat by feline herpesvirus type 1.
    Kawaguchi Y; Miyazawa T; Horimoto T; Itagaki S; Fukasawa M; Takahashi E; Mikami T
    Virology; 1991 Sep; 184(1):449-54. PubMed ID: 1651603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1.
    Kawaguchi Y; Norimine J; Miyazawa T; Kai C; Mikami T
    Virology; 1992 Sep; 190(1):465-8. PubMed ID: 1326814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes.
    Miyazawa T; Kohmoto M; Kawaguchi Y; Tomonaga K; Toyosaki T; Ikuta K; Adachi A; Mikami T
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1573-80. PubMed ID: 8393913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of insertion of multiple AP-1 binding sites into the U3 region of the long terminal repeat of feline immunodeficiency virus.
    Miyazawa T; Tomonaga K; Kawaguchi Y; Kohmoto M; Inoshima Y; Maeda K; Mikami T; Maedadel K [corrected to Maeda K]
    Arch Virol; 1994; 139(1-2):37-48. PubMed ID: 7529991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.
    Bigornia L; Lockridge KM; Sparger EE
    J Virol; 2001 Jan; 75(2):1054-60. PubMed ID: 11134320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient expression of the envelope protein of feline immunodeficiency virus in a recombinant feline herpesvirus type 1 (FHV-1) using the gC promoter of FHV-1.
    Sato E; Yokoyama N; Miyazawa T; Maeda K; Ikeda Y; Nishimura Y; Fujita K; Kohmoto M; Takahashi E; Mikami T
    Virus Res; 2000 Sep; 70(1-2):13-23. PubMed ID: 11074121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of feline immunodeficiency virus infection by stromal cell-derived factor.
    Hosie MJ; Broere N; Hesselgesser J; Turner JD; Hoxie JA; Neil JC; Willett BJ
    J Virol; 1998 Mar; 72(3):2097-104. PubMed ID: 9499065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of acute feline herpesvirus-1 and chronic feline immunodeficiency virus infections in experimentally infected specific pathogen free cats.
    Reubel GH; George JW; Barlough JE; Higgins J; Grant CK; Pedersen NC
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):95-119. PubMed ID: 1363011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vivo and in vitro interactions of feline immunodeficiency virus and feline leukemia virus.
    Beebe AM; Faith TG; Sparger EE; Torten M; Pedersen NC; Dandekar S
    AIDS; 1994 Jul; 8(7):873-8. PubMed ID: 7946095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth properties of a feline immunodeficiency virus mutant which lacks an AP-1 binding site in primary peripheral blood mononuclear cells.
    Miyazawa T; Inoshima Y; Kohmoto M; Ikeda Y; Mikami T
    J Vet Med Sci; 1994 Oct; 56(5):869-72. PubMed ID: 7532437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of feline immunodeficiency virus gene expression and replication by alphaherpesvirus ICP4 homologues.
    Kawaguchi Y; Maeda K; Miyazawa T; Ono M; Tsubota K; Tomonaga K; Mikami T
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2783-7. PubMed ID: 7931167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genome of feline immunodeficiency virus.
    Miyazawa T; Tomonaga K; Kawaguchi Y; Mikami T
    Arch Virol; 1994; 134(3-4):221-34. PubMed ID: 8129613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further development of a recombinant feline herpesvirus type 1 expressing the Gag protein of feline immunodeficiency virus.
    Sato E; Miyazawa T; Nishimura Y; Ikeda Y; Kawakami K; Mochizuki M; Yokoyama N; Maeda K; Fujita K; Kohmoto M; Takahashi E; Mikami T
    Arch Virol; 2001; 146(2):379-87. PubMed ID: 11315645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.